Innovative medicines for treatment of psoriatic arthritis

Автор: Levitan A.I., Reshetko O.V.

Журнал: Саратовский научно-медицинский журнал @ssmj

Рубрика: Дерматовенерология

Статья в выпуске: 3 т.11, 2015 года.

Бесплатный доступ

The problem of effective treatment of psoriatic arthritis has not been solved yet. The search for new therapeutic options is very active in many directions. At the stage of clinical trials are drugs that block interleukin-17-a (secukinumab, ixekizumab, brodalumab), drugs that suppress interleukin-12 and interleukin-23 (ustekinumab). To modern means to ensure psoriatic arthritis include drugs that are inhibitors of small molecules orkinase pathways (apremilast, tofacitinib).

Inhibitors of interleukin-17-a, inhibitors of interleukin-12, inhibitors of interleukin-23, psoriatic arthritis, janus-kinase inhibitor

Короткий адрес: https://sciup.org/14918165

IDR: 14918165

Статья научная